Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teplizumab, Sirolimus, and Tacrolimus in Islet Transplantation
NCT00265473Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2005
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of teplizumab in type 1 diabetes mellitus (T1D), sponsored by University of Minnesota. Started Nov 2005; status: completed.
02
Drugs
teplizumab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00265473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265473.